IGM Biosciences is a clinical-stage biotechnology company engaging in the development of Immunoglobulin M (IgM) antibodies for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases. Co.'s product candidates include: IGM-8444, which is an IgM antibody targeting Death Receptor 5 proteins for the treatment of patients with solid and hematologic malignancies; Imvotamab, which is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins; IGM-7354, which is an IgM antibody targeting the delivery of interleukin-15 to the area of PD-L1 expressing cells; and IGM-2644, which is a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins. We show 16 historical shares outstanding datapoints in our IGMS shares outstanding history coverage, used to compute IGMS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing IGMS market cap history over the course of time is important for investors
interested in comparing IGMS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of IGMS versus a peer is one thing; comparing
IGMS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like IGMS can fluctuate over the course of history.
With this page we aim to empower investors researching IGMS by allowing them to research the IGMS market cap history. |
Free IGMS Email Alerts:
Video: The Importance of Market Cap
